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Lay Summary: Competition often occurs among diverse parasites within a single host, but control
efforts could change its strength. We examined how the interplay between competition and control
could shape the evolution of parasite traits like drug resistance and disease severity.
Parasites often share their hosts with other parasites, meaning
that hosts infected by a single, homogenous parasite population
represent a rare exception. More commonly, hosts are infected
by a variety of pathogenic organisms—any of which we refer to
as ‘parasites’—that may themselves comprise multiple genetic
variants (‘strains’). Such diversity within the host can lead to
competition for resources or for respite from the shared threat of
host immune defenses. Within-host competition has long been a
focus of theoretical and experimental research in evolutionary
ecology, and it is now widely appreciated that competition can
alter the evolutionary trajectories of key parasite traits like viru-
lence (reviewed in [1]). Equally widespread is the recognition that
medical and public health interventions also drive the evolution
of parasite traits; drug resistance, for example, has made its way
to the forefront of our common conscience and our newsfeeds.
Yet the interactions between these two sources of selection pres-
sure are underexplored despite their inextricable linkage: by limit-
ing transmission between hosts and/or inhibiting replication
within hosts, control efforts—when successful—are likely to re-
duce the frequency and intensity of within-host competition. The
evolutionary consequences of such interactions for parasite traits
are as yet unmapped, and the implications for host health and
disease control remain uncertain.
Seeking to fill this gap and elucidate common principles—or
lack thereof—shaping parasite evolution in the presence of
competition and disease control, we recently held an interdis-
ciplinary workshop on this topic at Princeton University. The
workshop was organized by Nicole Mideo and Megan A.
Greischar as part of the NSF-funded Infectious Disease
Evolution Across Scales (IDEAS) Research Coordination
Network, with a combination of invited speakers and partici-
pants selected based on blinded review of applications (see au-
thor list). Here, we use the main discussion points of the
workshop as a guide to define the level of understanding
required to anticipate the evolutionary impact of feedbacks
among within-host interactions, epidemiological processes and
disease control, and we identify key open challenges for gener-
ating this understanding.
OUTSTANDING QUESTIONS IN EVOLUTION,
COMPETITION AND DISEASE CONTROL
When do single versus multiple infections yield distinct
health outcomes?
In evolutionary theory, infections are often categorized into two
types: single or multiple infections, with the latter implying two
or more different parasite strains (or species). This simple
dichotomy belies both the complexity of many human infectious
diseases and the myriad potential outcomes of competitive
interactions within the host, but it is nonetheless predicted to
have a large impact on host health. Is there any evidence that
the ‘precise’ diversity of an infection—the number of strains
represented by the ‘multiple’ moniker—needs to be considered
to understand clinical outcomes?
For HIV infections, the answer seems to be no. A lot can be
predicted about clinical outcomes from knowing simply
whether an infection was founded by one viral strain or more.
Infections founded by more than one strain tend to be more
virulent as they yield higher viral loads, which in turn hasten
progression to AIDS; in reality, most new infections are founded
by single strains [2 and references therein; NB: we use ‘strain’
here for consistency rather than ‘variant’ as favored in that lit-
erature]. The preponderance of infections founded by single
strains arises in part from the fact that transmission of multiple
viral particles is a prerequisite for inoculation with multiple
strains. Transmission of many viral particles is particularly likely
early on in HIV infections, before viral populations have diversi-
fied, and so relatively few strains are available for transmission
[2]. Widespread drug treatment should reduce still further the
odds of transmission during later stages of infection, and hence
inoculations with more than one viral strain [2]. Thus, relying on
the simple one-versus-many dichotomy, we may predict syner-
gistic effects of within-host ecology and drug treatment in
reducing virulence in HIV infections.
A similar ‘one-versus-many’ distinction emerges from study-
ing transmission of drug-resistant malaria strains. In untreated
rodent malaria infections, drug-resistant strains are competi-
tively suppressed by drug-sensitive competitors and fail to
transmit, regardless of whether competitors comprise one or
more strains [3]. Unlike our optimistic view for virulence in HIV
infections, as control efforts succeed in reducing the prevalence
of malaria infections, and coincidentally increasing the fre-
quency of single infections, drug-resistant strains may transmit
more efficiently (Fig. 1A). In a further contrast with HIV infec-
tions, the number of ‘distinct’ competitors seems crucial for
understanding disease severity in this system. In experimental
infections, increasing the number of strains elevates the total
parasite burden and exacerbates infection-induced anemia [3,
and references therein]. Thus, projecting how control efforts will
alter virulence in malaria requires understanding the distribu-
tion of strains within hosts, resolution that is not required to
predict consequences for the spread of drug resistance.
Altogether, evidence suggests that comparing single versus
multiple infections is sometimes useful (and, indeed, sufficient)
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for predicting health outcomes, but the patterns vary consider-
ably across and even within systems.
Do mechanisms underlying competition need to be
understood to make public health gains?
There is increasing interest in harnessing competition to
achieve particular public health outcomes, for example, delaying
or suppressing the emergence of drug resistance [4]. But com-
petition can take many forms, depending on the mechanistic
details of within-host interactions (e.g. direct resource competi-
tion, immune-mediated apparent competition and interference
competition; [1]) and it is not always clear what form (or forms)
are at play in any given system. Does this lack of mechanistic
understanding preclude exploiting within-host competition for
public health gain?
We suggest that the answer to this question is not necessar-
ily. If interventions can be found that mimic the beneficial
effects of competition and improve clinical outcomes, then—
whatever the underlying mechanisms—those interventions
should probably be deployed. However, an understanding of
mechanisms is likely to prove crucial for predicting the longer-
term consequences of those interventions, and in particular,
the parasite evolutionary responses that may erode or bolster
their direct effects. For example, intensifying resource competi-
tion may select for faster proliferating strains that cause more
harm to hosts. In contrast, enhancing interference competition
could select for slower-proliferating strains that produce more
energetically expensive compounds (e.g. bacteriocins) and
cause less harm to hosts [5]. Thus, the same control efforts that
reduce transmission, and the prevalence of multiple infections,
could have divergent evolutionary consequences for virulence
(Fig. 1B), which can only be predicted if mechanisms are
known. For public health, an important open challenge is identi-
fying the mechanistic basis for competitive interactions within
human hosts, as nearly all current data come from in vitro
experiments and model disease systems.
The mechanisms underlying competition also determine any
priority effects, where an initial infection alters the within-host
environment—positively or negatively—for subsequently colo-
nizing strains. An initial infection could make a host more vul-
nerable to later colonizing strains, for example by exhausting
host defenses. Alternately, a combination of resource and
immune-mediated apparent competition could reduce the suc-
cess of parasites that subsequently colonize a host. These prior-
ity effects can influence individual health outcomes as well as
evolutionary patterns, like the emergence of drug resistance. In
projecting the spread of drug resistance, it is useful to recog-
nize that drug-resistant strains are likely to appear at low dens-
ity in hosts already occupied by drug-sensitive strains. Applied
to malaria infections, models show that this numerical
disadvantage makes resistant strains more extinction-prone, a
disadvantage compounded by priority effects arising from
immune-mediated competition [6]. Although the numerical dis-
advantages (i.e. greater probability of extinction) are likely ubi-
quitous across systems when resistance arises de novo within a
host, those risks could be exaggerated or minimized depending
on the ecology governing how strains interact. In sum, the bulk
of evidence suggests that mechanistic understanding of compe-
tition is key to evaluating the long-term efficacy of public health
interventions.
How do within-host interactions scale up to influence
epidemiology?
Within-host interactions have the potential to alter critical epi-
demiological rates such as transmission, virulence and recov-
ery. But are there predictable patterns across, or even within,
host-parasite systems? Recovery rates are challenging to quan-
tify, especially for human infections where the timing of inocula-
tion is often unknown. However, times series of human malaria
infections—crucially, with known inoculation dates—provide a
basis for understanding the drivers of infection length. Childs
and Buckee [7] used those data to model transmission and in-
fection duration in single versus coinfections, finding that the
addition of a second strain can truncate or extend infection,
and may (or may not) make the host more infectious.
Outcomes in these cases depended on the timing of the infec-
tion and details about host immunity and prior exposure, bely-
ing the existence of simple rules for adjusting epidemiological
rates in the context of multiple infections.
A related challenge is that when diverse parasites generate
similar symptoms, it is difficult to even identify multiple infec-
tions, much less estimate their influence on epidemiological
processes. For example, Zika, dengue and chikungunya viruses
frequently co-circulate and present with similar, dengue-like
symptoms, so that infections composed of more than one of
these viruses may go undetected [reviewed in 8]. Passive case
detection relies on patients presenting at clinics and so cannot
reveal whether infections with multiple viruses are more (or
less) severe; that determination requires data that are currently
lacking on the prevalence of single versus multiple infections
among hosts with subclinical infections, i.e. cases where acute
symptoms are mild or absent [8]. Importantly, simultaneous in-
fection with two of these viruses can actually inhibit the devel-
opment of protective immunity against one of them [8],
rendering individuals potentially more susceptible to that virus
than if they had been exposed sequentially. Thus, predicting the
epidemiological consequences of co-circulation, including the
impact of coinfection on the progression of future epidemics,
depends critically on timing (akin to the priority effects noted
earlier). Common principles may become apparent as more
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data, generated through active surveillance, is brought to bear
on the question of individual health outcomes of coinfected
hosts and broader patterns of circulation. For now, existing
data show that multiple infections alter key epidemiological
parameters in hugely varied ways, defying straightforward
generalizations.
What is the evidence for indirect evolutionary effects of
disease control?
Direct evolutionary responses to interventions, like drug resist-
ance, are a predictable consequence of disease control, but con-
trol efforts may also exert unexpected, indirect evolutionary
pressures on parasite traits. Feedbacks between competition
and control represent a potentially crucial source of indirect se-
lection; e.g. if control efforts reduce the frequency of coinfec-
tions (e.g. Fig. 1A and B), parasites may evolve in response to
that altered competitive landscape. Devising experiments to de-
tect those outcomes requires clear theoretical predictions about
how parasite traits will evolve, but the complexity and idiosyn-
cratic nature of competitive interactions (as outlined above)
makes constructing those models a substantial, ongoing chal-
lenge (for an example of such a model, see [6]). Nonetheless,
existing theoretical and empirical studies show intriguing
possibilities for other unexpected, indirect evolutionary
consequences.
Even in the absence of competition, theory demonstrates the
potential for indirect selection via epidemiological feedbacks.
For example, epidemic expansion can select for earlier trans-
mission from malaria infections and more aggressive parasite
proliferation, to the detriment of host health [9]. That outcome
arises from the fact that while an epidemic is expanding, most
infections are in the early stages. Parasites therefore pay little
cost for traits, like aggressive proliferation, that jeopardize
transmission late in the course of infection [9 and references
therein]. By limiting the frequency of infections in early stages,
theory predicts that slowing epidemic expansion should yield
public health benefits beyond reducing prevalence [9]. For mal-
aria, those benefits could be even greater if control efforts also
reduce the frequency of coinfections thought to be costly to
health [Fig. 1B(ii)]. Although multiple sources of indirect selec-
tion may align to drive parasite evolution in ways beneficial to
Figure 1. Empirical insights on epidemiological feedbacks driving parasite
evolution. (A) Reducing transmission could lower multiple infection preva-
lence and thereby facilitate faster spread of resistance. Competition sup-
presses the transmission of drug resistance in rodent malaria parasites [3].
(B) Reducing transmission decreases multiple infection prevalence, increas-
ing (i) or decreasing (ii) virulence, depending on the mechanism of compe-
tition. (i) Entomopathogenic nematodes release mutualistic bacteria
(colored shapes) into host caterpillars after invading. Bacteria and nemato-
des grow separately until host death, when nematodes reacquire bacteria
and exit the cadaver. Bacteria strains interfere with one another—delaying
host death—by producing bacteriocins [reviewed in 1]. (ii) Coinfecting ro-
dent malaria strains (colored shapes) compete for resources, and diverse
infections generate greater anemia [3]. (C) Isolating superspreaders gener-
ates selection on per-parasite transmissibility. Artificial selection for produc-
tion of many nematodes (black squiggles) emerging from caterpillar
cadavers (i.e. superspreading) resulted in smaller nematodes—expected to
reduce transmissibility—compared with selection for the production of few
nematodes [10]
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public health, other systems may yield more nuanced out-
comes; such synergism would not be expected when a reduc-
tion in competition hastens host mortality [Fig. 1B(i)]. With
further theory across a range of systems, generalities may
emerge about when indirect selection is likely to reinforce the
public health gains of limiting transmission.
Detecting such long-term, evolutionary consequences of con-
trol—especially indirect effects—is a further challenge, but lab
studies can nonetheless highlight possible outcomes. For ex-
ample, artificial evolution experiments suggest that targeting
control to superspreaders could have unintended consequences
for the evolution of parasite traits underlying transmission.
Bashey and Lively [10] artificially selected for entomopathogenic
nematodes that produced many or few juveniles after invading
their insect hosts. The nematodes selected to produce few juve-
niles also produced larger ones, expected to be more transmis-
sible to new hosts [10]. Extrapolating from these experimental
results, public health interventions that isolate superspreaders
(e.g. quarantining hosts with high rates of shedding) could se-
lect for increased per-propagule infectivity to compensate for
lower shedding rates among the hosts who can still contribute
to transmission (Fig. 1C). Depending on the particular tradeoffs
at play, such parasite evolution could undercut the long-term
benefits of control.
Whether the effect is to enhance or undercut control efforts,
theory and experimental data demonstrate convincingly that
interventions can impose indirect selection on clinically and epi-
demiologically relevant parasite traits. A major outstanding
challenge is translating this work to human parasites and deter-
mining how to detect these subtler evolutionary consequences
of intervention efforts. Only then can we evaluate if they repre-
sent an important consideration in designing intervention
strategies.
CONCLUSIONS
Within-host competition and public health interventions are
both highly potent sources of selection on parasite traits.
Failing to account for the potential interactions between these
sources of selection can result in over- (or, sometimes, under-)
estimating the long-term efficacy of interventions, including re-
silience in the face of parasite evolution. Comparing across
case studies, we find a lack of consistent patterns in how com-
petition alters epidemiology and vice versa, precluding robust,
general predictions about parasite evolution. Indeed, current
evidence (Fig. 1) suggests a range of potential evolutionary out-
comes following control, both positive and negative from a pub-
lic health perspective. A critical challenge lies in translating
theory and experiments in model systems to expectations for
evolutionary responses in parasites of global health concern,
especially those subject to large-scale control efforts. Guiding
principles may emerge from a better understanding of the
mechanisms that govern within-host interactions in these
cases, narrowing the range of possible evolutionary outcomes.
Tracking the knock-on consequences of interventions requires
long-term data, ideally obtained through active surveillance
efforts that can detect how coinfections contribute to transmis-
sion and health burdens. In the meantime, existing data show
that the epidemiological feedbacks of altering competition can
drive parasite evolution in subtle, but important ways that de-
serve more attention.
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